LA PLAINE SAINT-DENIS, France

Serge Camelo

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Biophytis, Sorbonne Université, Centre National De La Recherche Scientifique. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge Camelo. Retrieved from https://idiyas.com/inventor/serge-camelo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Serge Camelo

Introduction

Serge Camelo is a notable inventor based in La Plaine Saint-Denis, France. He has made significant contributions to the field of ophthalmology through his innovative research and development of chemical compounds aimed at treating eye diseases. His work is particularly focused on conditions such as age-related macular degeneration and Stargardt's disease.

Latest Patents

Camelo holds a patent for chemical compounds targeting the eye, specifically derivatives of norbixin. This patent is aimed at altering the retinal pigment epithelium and is intended for use in the treatment of various eye diseases in mammals. The patent highlights the potential of these compounds in addressing critical health issues related to vision.

Career Highlights

Throughout his career, Serge Camelo has worked with prominent organizations, including Biophytis and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Some of his notable coworkers include Laurence Dinan and René Lafont. Their collaboration has likely enriched the research environment and fostered innovative solutions in the field of eye health.

Conclusion

Serge Camelo's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of eye diseases. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…